ADAMTS6 Promotes Angiogenesis and Tumor Growth in Gastric Carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family, particularly ADAMTS6, is implicated in cancer pathogenesis.
• Gastric carcinoma (GC) is a significant global health concern with complex underlying mechanisms.
• Understanding the role of specific genes like ADAMTS6 in GC progression is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the functional role of ADAMTS6 in gastric carcinoma (GC) tumor growth and angiogenesis.
• To evaluate ADAMTS6 as a potential prognostic biomarker and therapeutic target in GC.

Main Methods:

• Bioinformatic analysis of the TCGA-STAD dataset to identify GC prognostic genes correlated with angiogenesis.
• In vitro studies using GC cell lines with ADAMTS6 knockdown to assess proliferation, migration, invasion, and apoptosis.
• In vitro assessment of ADAMTS6's effect on human umbilical vein endothelial cell (HUVEC) angiogenesis via tube formation assay.
• In vivo studies using a GC xenograft mouse model to evaluate tumor growth, proliferation, apoptosis, and angiogenesis markers.

Main Results:

• ADAMTS6 was highly expressed in GC tissues and cell lines, correlating positively with poor prognosis and tumor angiogenesis.
• Silencing ADAMTS6 significantly inhibited GC cell proliferation, migration, and invasion, while promoting apoptosis in vitro.
• ADAMTS6 knockdown attenuated the pro-angiogenic effect on HUVECs and suppressed tumor growth, volume, and weight in vivo.
• Expression of angiogenesis-related markers was downregulated upon ADAMTS6 silencing.

Conclusions:

• ADAMTS6 plays a critical role in facilitating tumor growth and angiogenesis in gastric carcinoma.
• ADAMTS6 serves as a potential prognostic biomarker for GC.
• Targeting ADAMTS6 may represent a promising anti-angiogenic therapeutic strategy for GC.